Moxetumomab pasudotox-tdfk Intravenous and Zoladex (Goserelin Implant 3.6 mg)
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Zoladex (Goserelin Implant 3.6 mg) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: goserelin
Brand name: Zoladex
Synonyms: Zoladex
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Zoladex 3-Month
- Moxetumomab pasudotox-tdfk Intravenous-Zoladex Implant
- Moxetumomab pasudotox-tdfk Intravenous-Zolate
- Moxetumomab pasudotox-tdfk Intravenous-Zoledronic acid
- Moxetumomab pasudotox-tdfk Intravenous-Zoledronic Acid (Bone Health)
- Moxetumomab pasudotox-tdfk Intravenous-Zoledronic Acid (Zometa)
- Zoladex (Goserelin Implant 3.6 mg)-Moxifloxacin
- Zoladex (Goserelin Implant 3.6 mg)-Moxifloxacin (Systemic)
- Zoladex (Goserelin Implant 3.6 mg)-Moxifloxacin Hydrochloride
- Zoladex (Goserelin Implant 3.6 mg)-Moxifloxacin Injection
- Zoladex (Goserelin Implant 3.6 mg)-Moxifloxacin Intravenous
- Zoladex (Goserelin Implant 3.6 mg)-Moxifloxacin Tablets